Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2019

16.11.2018 | Rhinology

The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps

verfasst von: Lijie Jiang, Min Zhou, Jie Deng, Yueqi Sun, Kejun Zuo, Rui Zheng, Jianbo Shi, Yinyan Lai

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Glucocorticoids are the first-line medical treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), whose local metabolism is catalyzed by 11β-HSD1 and 11β-HSD2. This study investigates the role of 11β-HSD1 and 11β-HSD2 on the glucocorticoid response of CRSwNP patients and the pathogenic mechanism of these polyps.

Methods

Forty-three adult CRSwNP patients were enrolled in this study. We evaluated the endoscopic scores by a nasal polyp grading system before and after treatment. We estimated the response to glucocorticoids by the total endoscopic scores. The logistic regression models and inflammatory characteristic curves were conducted to explore the prediction of the response to glucocorticoid in CRSwNP. The expression of 11β-HSD1 and 11β-HSD2 on human sinonasal epithelial cells (HSECS) was measured under the stimulation of toll-like receptor agonists and dexamethasone.

Results

The endoscopic scores in the CRSwNP group declined, the expression of 11β-HSD1/11β-HSD2 increased (r = 0.5276, P = 0.0011), and the cutoff value of the ratio of 11β-HSD1/11β-HSD2 was 0.4654 (sensitivity 79.17%, specificity 88.89%). Dexamethasone induced a decrease in the ratio of 11β-HSD1/11β-HSD2 (P = 0.049) by the stimulation of PGN-BS.

Conclusion

We found a strong correlation between the response to glucocorticoids and the ratio of 11β-HSD1/11β-HSD2, which could be used as a marker in predicting the level of tissue response to glucocorticoid therapy in CRSwNP. In addition, PGN-BS could also be a therapeutic target, as it is the negative factor that will decrease the sensitivity of glucocorticoids by reducing the ratio of 11β-HSD1/11β-HSD2.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012(23):3 (preceding table of contents, 1–298) Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012(23):3 (preceding table of contents, 1–298)
3.
Zurück zum Zitat Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T et al (2012) Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 67(1):91–98 CrossRefPubMed Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T et al (2012) Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 67(1):91–98 CrossRefPubMed
4.
Zurück zum Zitat Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P et al (2001) Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107(1):73–80 CrossRefPubMed Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P et al (2001) Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107(1):73–80 CrossRefPubMed
8.
Zurück zum Zitat Grzanka A, Misiolek M, Golusinski W, Jarzab J (2011) Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis. Eur Arch Otorhinolaryngol 268(2):247–253 CrossRefPubMed Grzanka A, Misiolek M, Golusinski W, Jarzab J (2011) Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis. Eur Arch Otorhinolaryngol 268(2):247–253 CrossRefPubMed
10.
Zurück zum Zitat Orsida BE, Krozowski ZS, Walters EH (2002) Clinical relevance of airway 11 β-hydroxysteroid dehydrogenase type II enzyme in asthma. Am J Respir Crit Care Med 165(7):1010–1014 CrossRefPubMed Orsida BE, Krozowski ZS, Walters EH (2002) Clinical relevance of airway 11 β-hydroxysteroid dehydrogenase type II enzyme in asthma. Am J Respir Crit Care Med 165(7):1010–1014 CrossRefPubMed
11.
Zurück zum Zitat Hennebold JD, Ryu SY, Mu HH, Galbraith A, Daynes RA (1996) 11 beta-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am J Physiol 270(2):1296–1306 Hennebold JD, Ryu SY, Mu HH, Galbraith A, Daynes RA (1996) 11 beta-hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am J Physiol 270(2):1296–1306
12.
Zurück zum Zitat Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR (2006) Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Ann N Y Acad Sci 1088(1):265 CrossRefPubMed Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR (2006) Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Ann N Y Acad Sci 1088(1):265 CrossRefPubMed
13.
Zurück zum Zitat Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR (2013) Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol 137(100):82 CrossRefPubMedPubMedCentral Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR (2013) Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol 137(100):82 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP et al (2008) Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol Endocrinol 22(9):2049–2060 CrossRefPubMedPubMedCentral Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP et al (2008) Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol Endocrinol 22(9):2049–2060 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ergang P, Leden P, Bryndova J, Zbankova S, Miksik I, Kment M et al (2008) Glucocorticoid availability in colonic inflammation of rat. Dig Dis Sci 53(8):2160–2167 CrossRefPubMed Ergang P, Leden P, Bryndova J, Zbankova S, Miksik I, Kment M et al (2008) Glucocorticoid availability in colonic inflammation of rat. Dig Dis Sci 53(8):2160–2167 CrossRefPubMed
16.
Zurück zum Zitat Abbott AN, Guidry TV, Welsh KJ, Thomas AM, Kling MA, Hunter RL et al (2009) 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6′-dimycolate. Neuroimmunomodulation 16(3):147–154 CrossRefPubMed Abbott AN, Guidry TV, Welsh KJ, Thomas AM, Kling MA, Hunter RL et al (2009) 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6′-dimycolate. Neuroimmunomodulation 16(3):147–154 CrossRefPubMed
17.
Zurück zum Zitat Stegk JP, Ebert B, Martin HJ, Maser E (2009) Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol 301(1–2):104–108 CrossRefPubMed Stegk JP, Ebert B, Martin HJ, Maser E (2009) Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol 301(1–2):104–108 CrossRefPubMed
18.
Zurück zum Zitat Jun YJ, Park SJ, Kim TH, Lee SH, Lee KJ, Hwang SM et al (2014) Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa. J Allergy Clin Immunol 134(4):926–934e6 CrossRefPubMed Jun YJ, Park SJ, Kim TH, Lee SH, Lee KJ, Hwang SM et al (2014) Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa. J Allergy Clin Immunol 134(4):926–934e6 CrossRefPubMed
19.
Zurück zum Zitat Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM et al (2015) A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 46(3):622–639 CrossRefPubMedPubMedCentral Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM et al (2015) A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 46(3):622–639 CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al (2006) Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118(5 Suppl):S17–S61 CrossRefPubMed Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al (2006) Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118(5 Suppl):S17–S61 CrossRefPubMed
21.
Zurück zum Zitat Milara J, Morell A, Ballester B, Armengot M, Morcillo E, Cortijo J (2017) MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 139(3):855–862e13 CrossRefPubMed Milara J, Morell A, Ballester B, Armengot M, Morcillo E, Cortijo J (2017) MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 139(3):855–862e13 CrossRefPubMed
22.
Zurück zum Zitat Lai Y, Chen B, Shi J, Palmer JN, Kennedy DW, Cohen NA (2011) Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhinosinusitis. J Allergy Clin Immunol 128(6):1207–1215e1 CrossRefPubMed Lai Y, Chen B, Shi J, Palmer JN, Kennedy DW, Cohen NA (2011) Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhinosinusitis. J Allergy Clin Immunol 128(6):1207–1215e1 CrossRefPubMed
23.
Zurück zum Zitat Ma Y, Sun Y, Jiang L, Zuo K, Chen H, Guo J et al (2017) WDPCP regulates the ciliogenesis of human sinonasal epithelial cells in chronic rhinosinusitis. Cytoskeleton (Hoboken) 74(2):82–90 CrossRef Ma Y, Sun Y, Jiang L, Zuo K, Chen H, Guo J et al (2017) WDPCP regulates the ciliogenesis of human sinonasal epithelial cells in chronic rhinosinusitis. Cytoskeleton (Hoboken) 74(2):82–90 CrossRef
24.
Zurück zum Zitat Milara J, Peiro T, Armengot M, Frias S, Morell A, Serrano A et al (2015) Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 135(2):470–476 CrossRefPubMed Milara J, Peiro T, Armengot M, Frias S, Morell A, Serrano A et al (2015) Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 135(2):470–476 CrossRefPubMed
25.
Zurück zum Zitat Yang JY, Kim MS, Kim E, Cheon JH, Lee YS, Kim Y et al (2016) Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-beta production. Immunity 44(4):889–900 CrossRefPubMed Yang JY, Kim MS, Kim E, Cheon JH, Lee YS, Kim Y et al (2016) Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-beta production. Immunity 44(4):889–900 CrossRefPubMed
26.
Zurück zum Zitat Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413(6857):732–738 CrossRef Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413(6857):732–738 CrossRef
27.
Zurück zum Zitat Dziarski R, Gupta D (2005) Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immunity 73(8):5212 CrossRef Dziarski R, Gupta D (2005) Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immunity 73(8):5212 CrossRef
28.
Zurück zum Zitat Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA et al (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of toll-like receptor 7. Proc Natl Acad Sci USA 100(11):6646–6651 CrossRefPubMed Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA et al (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of toll-like receptor 7. Proc Natl Acad Sci USA 100(11):6646–6651 CrossRefPubMed
29.
Zurück zum Zitat Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663):1526–1529 CrossRef Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663):1526–1529 CrossRef
30.
Zurück zum Zitat Funder JW (1997) Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48(1):231–240 CrossRefPubMed Funder JW (1997) Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48(1):231–240 CrossRefPubMed
31.
Zurück zum Zitat Suzuki S, Koyama K, Darnel A, Ishibashi H, Kobayashi S, Kubo H et al (2003) Dexamethasone upregulates 11beta-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells. Am J Respir Crit Care Med 167(9):1244–1249 CrossRefPubMed Suzuki S, Koyama K, Darnel A, Ishibashi H, Kobayashi S, Kubo H et al (2003) Dexamethasone upregulates 11beta-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells. Am J Respir Crit Care Med 167(9):1244–1249 CrossRefPubMed
32.
Zurück zum Zitat Park SJ, Kook JH, Kim HK, Kang SH, Lim SH, Kim HJ et al (2015) Macrolides increase the expression of 11beta-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa. Br J Pharmacol 172(21):5083–5095 CrossRefPubMedPubMedCentral Park SJ, Kook JH, Kim HK, Kang SH, Lim SH, Kim HJ et al (2015) Macrolides increase the expression of 11beta-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa. Br J Pharmacol 172(21):5083–5095 CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Josephson MB, Jiao J, Xu S, Hu A, Paranjape C, Grunstein JS et al (2012) IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response. Am J Physiol Lung Cell Mol Physiol 303(5):L382–L390 CrossRefPubMedPubMedCentral Josephson MB, Jiao J, Xu S, Hu A, Paranjape C, Grunstein JS et al (2012) IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response. Am J Physiol Lung Cell Mol Physiol 303(5):L382–L390 CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Bryndova J, Zbankova S, Kment M, Pacha J (2004) Colitis up-regulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand J Gastroenterol 39(6):549–553 CrossRefPubMed Bryndova J, Zbankova S, Kment M, Pacha J (2004) Colitis up-regulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand J Gastroenterol 39(6):549–553 CrossRefPubMed
35.
Zurück zum Zitat Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM et al (2008) Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis 67(9):1204–1210 CrossRefPubMedPubMedCentral Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM et al (2008) Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis 67(9):1204–1210 CrossRefPubMedPubMedCentral
Metadaten
Titel
The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps
verfasst von
Lijie Jiang
Min Zhou
Jie Deng
Yueqi Sun
Kejun Zuo
Rui Zheng
Jianbo Shi
Yinyan Lai
Publikationsdatum
16.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5201-3

Weitere Artikel der Ausgabe 1/2019

European Archives of Oto-Rhino-Laryngology 1/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.